Le Lézard
Classified in: Health, Business
Subjects: WOM, CXP

Nurx Launches In Georgia, Offering Home Delivery Of Affordable Birth Control And HIV Prevention


SAN FRANCISCO, Aug. 6, 2018 /PRNewswire/ -- Nurx, the leading telemedicine platform offering birth control and HIV prevention prescriptions for home delivery, is now available in Georgia. The company offers free online consultation with medical providers who can prescribe these critical health medications, dramatically increasing access to high quality reproductive care. Nurx also launches today in Tennessee, making the platform now available in 20 states and Washington, D.C. 

Nurx App

In the app, users can choose from over 50 birth control brands, receive consultation and prescriptions with a state-licensed provider, and opt in to automatic refills. Shipments are mailed in discreet packaging and at no extra cost. Nurx is available to both insured and uninsured users. For those with insurance, prescriptions are either free or the cost of one's copay. For those without insurance, affordable brands and cost-effective generic options are available.

According to research from the Guttmacher Institute, in 2010, 60% of all pregnancies in Georgia were unintended. Nurx's online platform and home delivery provide greater access to reproductive care for those who live in both urban or more rural locations known as "contraceptive deserts." For the south's geographically dispersed population especially, access to family planning centers can be limited.

"The National Campaign to Prevent Teen and Unplanned Pregnancy estimates nearly 20 million women live without reasonable access to a full range of contraceptive options, and over three million live in a county without a single clinic," said Hans Gangeskar, co-founder and CEO of Nurx. "State by state, we are launching Nurx to create equity in healthcare access for all Americans through this urgent telehealth option."

Committed to giving users full control of their sexual health, Nurx also delivers Georgia residents pre-exposure prophylaxis, also known as PrEP, for HIV prevention. This is an HIV prevention method in which a daily pill is taken to reduce chances of infection. Studies have shown PrEP to be up to 99% effective at preventing transmission of the HIV virus when taken every day as directed.

Nurx's launch in Georgia comes at a time when data from the Centers for Disease Control and Prevention show the state has reached an epidemic level of HIV-positive rates. According to 2016 statistics, Georgia's HIV infection rates are the highest in the country and more than double the national average, with 31.8 cases per 100,000 people. Statistics have also shown that, overall, Southern states have the highest number of new HIV diagnoses in the U.S. but has disproportionately fewer people using anti-HIV treatment. This means that despite being the state with the highest rate of new HIV diagnosis, Georgia is not in the top ten for PrEP use.

"The CDC predicts that one in five Georgians will be diagnosed with HIV in their lifetime," said Jessica Horwitz, Medical Director at Nurx. "Health disparities like this are unacceptable. Especially when we know that comprehensive education and PrEP access can significantly reduce new HIV infection rates. Access to quality medical care is a basic human right and that includes access to these life-saving medications, regardless of where you live."

Former First Daughter and global public health leader Chelsea Clinton, who recently joined as Nurx's newest board member, advocates for expanding access to healthcare and empowering girls and women across America.

"By putting individuals in control of their personal health, and by starting with critical health needs like birth control and HIV prevention, Nurx is well-positioned to make a difference in the lives of countless Americans," said Chelsea Clinton. "I'm delighted to join their board, and excited to help them empower people to build better futures for themselves and realize a vision of accessible, affordable care for all."

Founded in 2015 by Hans Gangeskar and Dr. Edvard Engesæth, Nurx's medical platform integrates an owned-and-operated pharmacy, a network of partner physicians, and a mobile telehealth app to create a seamless, end-to-end digital health experience for customers. Today, Nurx operates in 20 states and the District of Columbia, and is available to more than 70% of the U.S. population.

Nurx's telemedicine service is currently available to residents in California, Colorado, Florida, Georgia, Indiana, Illinois, Massachusetts, Michigan, Minnesota, Missouri, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Tennessee, Texas, Virginia, Washington and Wisconsin. The company operates according to state and federal standards, including HIPPAA.

About Nurx
Nurx is a telemedicine platform offering easy online access to doctors and seamless delivery of medications. No more time-consuming trips to the clinic and no more frantic pharmacy runs. We put you in control of your own health, empowering you to get the care you need, when you need it. Starting with birth control and PrEP for HIV prevention, Nurx is available in 20 states and counting. From diagnosis to delivery of prescriptions, we make every part of getting healthy and staying healthy, better. For more information and to signup, visit www.nurx.com and follow us @nurxapp on Twitter and Instagram.

 

Nurx Logo (PRNewsfoto/Nurx)

SOURCE Nurx


These press releases may also interest you

at 04:25
Ademi LLP is investigating Doma  for possible breaches of fiduciary duty and other violations of law in its transaction with Title Resources Group. ...

at 04:00
U Power Limited (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that the Company held an extraordinary general meeting of...

at 04:00
Tonight on BBC1, REMY founder Abeer Iqbal, entered the Den, and despite intense grilling and no investment, left with a six-figure job offer from Peter Jones. ...

at 04:00
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against The Chemours Company ("Chemours" or "the Company") and certain of its officers....

at 03:57
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of those who held the common stock of Northern Genesis Acquisition Corp. n/k/a The Lion Electric Company as of the record date of March...

at 03:44
Bitrue, a leading cryptocurrency exchange serving over 10 million users globally, announces a focus on user behavior analysis to further develop the utility of its native token, Bitrue Coin (BTR). "Understanding how our users interact with BTR is...



News published on and distributed by: